Debiopharm Innovation Fund Investors
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.
Invests into
Headquarters:
Lausanne, Vaud, Switzerland
Number Of Exists:
6
Founded Date:
2012-01-01
Acquisitions Number:
NA
Employee Number:
1-10
Investment Stage:
Late Stage Venture, Venture
Investor Type:
Venture Capital
Investors Number:
24
Zip:
NA
Funding Status:
N/A
Estimated Revenue:
$4.7M.
Industry:
Imaging